Test | Time period | Incidence rate ratio | Lower 95% CI | Upper 95% CI | P-value | Type 3 p-value |
Overall | 0.043* | |||||
Preimplementation | 1.004 | 1.001 | 1.007 | |||
During-implementation | 1.002 | 0.999 | 1.004 | |||
Postimplementation | 1.007 | 1.004 | 1.010 | |||
Postimplementation vs Preimplementation | 1.003 | 0.999 | 1.007 | 0.108 | ||
Estimated intervention effect | 0.989 | 0.943 | 1.037 | 0.645 | ||
UEC | 0.090 | |||||
Preimplementation | 1.003 | 1.001 | 1.006 | |||
During-implementation | 1.003 | 1.000 | 1.005 | |||
Postimplementation | 1.008 | 1.005 | 1.011 | |||
Postimplementation vs Preimplementation | 1.004 | 1.000 | 1.008 | 0.030* | ||
Estimated intervention effect | 0.981 | 0.938 | 1.025 | 0.382 | ||
FBC | 0.017* | |||||
Preimplementation | 1.004 | 1.001 | 1.008 | |||
During-implementation | 1.001 | 0.998 | 1.004 | |||
Postimplementation | 1.008 | 1.005 | 1.011 | |||
Postimplementation vs Preimplementation | 1.004 | 0.999 | 1.008 | 0.092 | ||
Estimated intervention effect | 0.976 | 0.917 | 1.037 | 0.429 | ||
Troponin | 0.640 | |||||
Preimplementation | 1.009 | 0.999 | 1.019 | |||
During-implementation | 1.008 | 0.997 | 1.019 | |||
Postimplementation | 1.001 | 0.988 | 1.013 | |||
Postimplementation vs Preimplementation | 0.992 | 0.976 | 1.008 | 0.339 | ||
Estimated intervention effect | 0.978 | 0.794 | 1.207 | 0.839 | ||
TSH | 0.005* | |||||
Preimplementation | 1.019 | 1.006 | 1.033 | |||
During-implementation | 0.965 | 0.954 | 0.977 | |||
Postimplementation | 1.013 | 1.004 | 1.022 | |||
Postimplementation vs Preimplementation | 0.994 | 0.978 | 1.010 | 0.443 | ||
Estimated intervention effect | 0.769 | 0.600 | 0.985 | 0.038* | ||
Vitamin D | 0.099 | |||||
Preimplementation | 1.029 | 1.011 | 1.048 | |||
During-implementation | 1.003 | 0.972 | 1.034 | |||
Postimplementation | 0.998 | 0.982 | 1.014 | |||
Postimplementation vs Preimplementation | 0.969 | 0.947 | 0.992 | 0.010* | ||
Estimated intervention effect | 0.650 | 0.466 | 0.907 | 0.011* | ||
HbA1c | 0.242 | |||||
Preimplementation | 1.001 | 0.992 | 1.011 | |||
During-implementation | 0.990 | 0.981 | 0.999 | |||
Postimplementation | 0.989 | 0.980 | 0.999 | |||
Postimplementation vs Preimplementation | 0.988 | 0.975 | 1.002 | 0.086 | ||
Estimated intervention effect | 1.045 | 0.868 | 1.259 | 0.640 | ||
CRP | 0.154 | |||||
Preimplementation | 1.014 | 1.002 | 1.026 | |||
During-implementation | 1.007 | 0.997 | 1.018 | |||
Postimplementation | 1.000 | 0.994 | 1.006 | |||
Postimplementation vs Preimplementation | 0.987 | 0.974 | 1.000 | 0.044* | ||
Estimated intervention effect | 1.099 | 0.893 | 1.353 | 0.374 |
For each test, the ‘post vs pre’ line reflects the slope change, and the ‘estimated intervention effect’ line reflects the step change.
*Significant at <0.05.
CRP, C reactive protein; FBC, full blood count; TSH, thyroid-stimulating hormone; UEC, urea, electrolytes and creatinine.